Följ
Rui Batista
Rui Batista
Institute of Pathology and Molecular Imunology of the University of Porto
Verifierad e-postadress på ipatimup.pt - Startsida
Titel
Citeras av
Citeras av
År
Frequency of TERT promoter mutations in human cancers
J Vinagre, A Almeida, H Pópulo, R Batista, J Lyra, V Pinto, R Coelho, ...
Nature communications 4 (1), 2185, 2013
9742013
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas
M Melo, AG da Rocha, J Vinagre, R Batista, J Peixoto, C Tavares, ...
The Journal of Clinical Endocrinology & Metabolism 99 (5), E754-E765, 2014
5842014
TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation
H Pópulo, P Boaventura, J Vinagre, R Batista, A Mendes, R Caldas, ...
Journal of Investigative Dermatology 134 (8), 2251-2257, 2014
1402014
TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease
M Melo, A Gaspar da Rocha, R Batista, J Vinagre, MJ Martins, G Costa, ...
The Journal of Clinical Endocrinology & Metabolism 102 (6), 1898-1907, 2017
1332017
Biomarkers for bladder cancer diagnosis and surveillance: a comprehensive review
R Batista, N Vinagre, S Meireles, J Vinagre, H Prazeres, R Leão, ...
Diagnostics 10 (1), 39, 2020
972020
NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features
C Tavares, MJ Coelho, C Eloy, M Melo, AG da Rocha, A Pestana, ...
Endocrine connections 7 (1), 78-90, 2018
692018
The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism
R Batista, A Cruvinel‐Carloni, J Vinagre, J Peixoto, TA Catarino, ...
International journal of cancer 139 (2), 414-423, 2016
682016
Validation of a novel, sensitive, and specific urine-based test for recurrence surveillance of patients with non-muscle-invasive bladder cancer in a comprehensive multicenter study
R Batista, J Vinagre, H Prazeres, C Sampaio, P Peralta, R Leão, ...
Frontiers in genetics 10, 476439, 2019
562019
TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma
MA Campos, S Macedo, M Fernandes, A Pestana, J Pardal, R Batista, ...
Journal of the American Academy of Dermatology 80 (3), 660-669. e6, 2019
382019
mTOR activation in medullary thyroid carcinoma with RAS mutation
J Lyra, J Vinagre, R Batista, V Pinto, H Prazeres, F Rodrigues, C Eloy, ...
European journal of endocrinology 171 (5), 633-640, 2014
382014
mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression
C Tavares, C Eloy, M Melo, A Gaspar da Rocha, A Pestana, R Batista, ...
International journal of molecular sciences 19 (5), 1448, 2018
372018
Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior
LB Ferreira, C Tavares, A Pestana, CL Pereira, C Eloy, MT Pinto, P Castro, ...
Oncotarget 7 (32), 52003, 2016
342016
Clinical Validation of a Urine Test (Uromonitor-V2®) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients
CA Sieverink, RPM Batista, HJM Prazeres, J Vinagre, C Sampaio, ...
Diagnostics 10 (10), 745, 2020
262020
Multinodular goiter progression toward malignancy in a case of DICER1 syndrome: histologic and molecular alterations
I Gullo, R Batista, P Rodrigues-Pereira, P Soares, H Barroca, ...
American journal of clinical pathology 149 (5), 379-386, 2018
262018
Genetic determinants for prediction of outcome of patients with papillary thyroid carcinoma
AA Póvoa, E Teixeira, MR Bella-Cueto, R Batista, A Pestana, M Melo, ...
Cancers 13 (9), 2048, 2021
252021
Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas
P Boaventura, D Pereira, A Mendes, R Batista, AF da Silva, I Guimaraes, ...
Journal of Dermatological Science 73 (1), 31-39, 2014
252014
TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients
R Batista, L Lima, J Vinagre, V Pinto, J Lyra, V Máximo, L Santos, ...
International journal of molecular sciences 21 (3), 947, 2020
232020
Etiopathogenesis of oncocytomas
M Correia, P Pinheiro, R Batista, P Soares, M Sobrinho-Simões, ...
Seminars in cancer biology 47, 82-94, 2017
182017
Inhibitory effects of antagonists of growth hormone-releasing hormone (GHRH) in thyroid cancer
H Pópulo, B Nunes, C Sampaio, R Batista, MT Pinto, TB Gaspar, ...
Hormones and Cancer 8, 314-324, 2017
182017
Loss of mitochondrial SDHB expression: what is its role in diffuse thyroid lipomatosis?
E Lau, P Freitas, J Costa, R Batista, V Máximo, R Coelho, L Matos-Lima, ...
Hormone and Metabolic Research 47 (03), 165-167, 2015
182015
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20